Expert Pharmacy Insights
Evidence-based health articles, medication guides, and wellness tips from certified pharmacists
Budesonide with Formoterol Inhalers: Doses, MART and What the Trials Show
Budesonide with formoterol is the only inhaled steroid and long-acting beta agonist combination that can serve as both preventer and reliever. SYGMA 1 cut severe exacerbations from 0.20 to 0.07 per year on 17 percent of the steroid dose, and the CARE trial in children reported 0.23 versus 0.41 attacks per year against salbutamol. This guide covers the trial numbers, strength conventions across Foracort and Symbicort, device choice and where the combination is the wrong answer.
Montelukast Side Effects: What the Trial Data and the Boxed Warning Actually Say
Montelukast trial data and boxed warning read very differently. In placebo-controlled trials the adverse reaction rates were nearly identical to placebo, with headache at 18.4 percent versus 18.1 percent on placebo. The 2020 FDA boxed warning came from post-marketing reports instead. This guide separates the two, with the full Table 1 rates, the psychiatric reports list, paediatric data and dosing by age.
Showing 6-7 of 7 articles